A phase III open-label safety and efficacy study of tomoxetine hydrochloride in outpatients with ADHD, Ages 6 to 18 years

Document Type

Article

Date of Publication

10-2000

Publication Title

Protocol * B4Z-MC-LYAB(a),

This document is currently not available here.

Share

COinS